1 Market Overview

1.1 Product Overview and Scope of Pharmaceutical Regulatory Affairs

1.2 Classification of Pharmaceutical Regulatory Affairs by Type

1.2.1 Overview: Global Pharmaceutical Regulatory Affairs Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type in 2020

1.2.3 Regulatory Consulting

1.2.4 Legal Representation

1.2.5 Regulatory Writing & Publishing

1.2.6 Product Registration & Clinical Trial Application

1.2.7 Other Services

1.3 Global Pharmaceutical Regulatory Affairs Market by Application

1.3.1 Overview: Global Pharmaceutical Regulatory Affairs Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 In-house

1.3.3 Outsourcing

1.4 Global Pharmaceutical Regulatory Affairs Market Size & Forecast

1.5 Global Pharmaceutical Regulatory Affairs Market Size and Forecast by Region

1.5.1 Global Pharmaceutical Regulatory Affairs Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Pharmaceutical Regulatory Affairs Market Size by Region, (2016-2021)

1.5.3 North America Pharmaceutical Regulatory Affairs Market Size and Prospect (2016-2026)

1.5.4 Europe Pharmaceutical Regulatory Affairs Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size and Prospect (2016-2026)

1.5.6 South America Pharmaceutical Regulatory Affairs Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Pharmaceutical Regulatory Affairs Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharmaceutical Regulatory Affairs Market Drivers

1.6.2 Pharmaceutical Regulatory Affairs Market Restraints

1.6.3 Pharmaceutical Regulatory Affairs Trends Analysis

2 Company Profiles

2.1 QuintilesIMS

2.1.1 QuintilesIMS Details

2.1.2 QuintilesIMS Major Business

2.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Product and Solutions

2.1.4 QuintilesIMS Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 QuintilesIMS Recent Developments and Future Plans

2.2 LabCor

2.2.1 LabCor Details

2.2.2 LabCor Major Business

2.2.3 LabCor Pharmaceutical Regulatory Affairs Product and Solutions

2.2.4 LabCor Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 LabCor Recent Developments and Future Plans

2.3 PAREXEL

2.3.1 PAREXEL Details

2.3.2 PAREXEL Major Business

2.3.3 PAREXEL Pharmaceutical Regulatory Affairs Product and Solutions

2.3.4 PAREXEL Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 PAREXEL Recent Developments and Future Plans

2.4 Pharmaceutical Product Development

2.4.1 Pharmaceutical Product Development Details

2.4.2 Pharmaceutical Product Development Major Business

2.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product and Solutions

2.4.4 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Pharmaceutical Product Development Recent Developments and Future Plans

2.5 INC RESEARCH HOLDINGS

2.5.1 INC RESEARCH HOLDINGS Details

2.5.2 INC RESEARCH HOLDINGS Major Business

2.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product and Solutions

2.5.4 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 INC RESEARCH HOLDINGS Recent Developments and Future Plans

2.6 PRA Health Sciences

2.6.1 PRA Health Sciences Details

2.6.2 PRA Health Sciences Major Business

2.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Product and Solutions

2.6.4 PRA Health Sciences Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 PRA Health Sciences Recent Developments and Future Plans

2.7 ICON

2.7.1 ICON Details

2.7.2 ICON Major Business

2.7.3 ICON Pharmaceutical Regulatory Affairs Product and Solutions

2.7.4 ICON Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 ICON Recent Developments and Future Plans

2.8 Charles River

2.8.1 Charles River Details

2.8.2 Charles River Major Business

2.8.3 Charles River Pharmaceutical Regulatory Affairs Product and Solutions

2.8.4 Charles River Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Charles River Recent Developments and Future Plans

2.9 Advent International

2.9.1 Advent International Details

2.9.2 Advent International Major Business

2.9.3 Advent International Pharmaceutical Regulatory Affairs Product and Solutions

2.9.4 Advent International Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Advent International Recent Developments and Future Plans

2.10 WuXi AppTec, Inc.

2.10.1 WuXi AppTec, Inc. Details

2.10.2 WuXi AppTec, Inc. Major Business

2.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product and Solutions

2.10.4 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 WuXi AppTec, Inc. Recent Developments and Future Plans

2.11 Pharmaron Beijing Co., Ltd.

2.11.1 Pharmaron Beijing Co., Ltd. Details

2.11.2 Pharmaron Beijing Co., Ltd. Major Business

2.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product and Solutions

2.11.4 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Pharmaron Beijing Co., Ltd. Recent Developments and Future Plans

2.12 Hangzhou Tigermed Consulting Co.,Ltd.

2.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Details

2.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Major Business

2.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product and Solutions

2.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Recent Developments and Future Plans

2.13 Asymchem Laboratories (Tianjin) Co.,Ltd.

2.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Details

2.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Major Business

2.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product and Solutions

2.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Developments and Future Plans

2.14 Accell Clinical Research, LLC.

2.14.1 Accell Clinical Research, LLC. Details

2.14.2 Accell Clinical Research, LLC. Major Business

2.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product and Solutions

2.14.4 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Accell Clinical Research, LLC. Recent Developments and Future Plans

2.15 GenPact Ltd.

2.15.1 GenPact Ltd. Details

2.15.2 GenPact Ltd. Major Business

2.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Product and Solutions

2.15.4 GenPact Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 GenPact Ltd. Recent Developments and Future Plans

2.16 Criterium, Inc.

2.16.1 Criterium, Inc. Details

2.16.2 Criterium, Inc. Major Business

2.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Product and Solutions

2.16.4 Criterium, Inc. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Criterium, Inc. Recent Developments and Future Plans

2.17 Promedica International

2.17.1 Promedica International Details

2.17.2 Promedica International Major Business

2.17.3 Promedica International Pharmaceutical Regulatory Affairs Product and Solutions

2.17.4 Promedica International Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Promedica International Recent Developments and Future Plans

2.18 Medpace

2.18.1 Medpace Details

2.18.2 Medpace Major Business

2.18.3 Medpace Pharmaceutical Regulatory Affairs Product and Solutions

2.18.4 Medpace Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Medpace Recent Developments and Future Plans

2.19 Covance

2.19.1 Covance Details

2.19.2 Covance Major Business

2.19.3 Covance Pharmaceutical Regulatory Affairs Product and Solutions

2.19.4 Covance Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Covance Recent Developments and Future Plans

2.20 Freyr

2.20.1 Freyr Details

2.20.2 Freyr Major Business

2.20.3 Freyr Pharmaceutical Regulatory Affairs Product and Solutions

2.20.4 Freyr Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Freyr Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmaceutical Regulatory Affairs Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharmaceutical Regulatory Affairs Players Market Share

3.2.2 Top 10 Pharmaceutical Regulatory Affairs Players Market Share

3.2.3 Market Competition Trend

3.3 Pharmaceutical Regulatory Affairs Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pharmaceutical Regulatory Affairs Revenue and Market Share by Type (2016-2021)

4.2 Global Pharmaceutical Regulatory Affairs Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Application (2016-2021)

5.2 Pharmaceutical Regulatory Affairs Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Pharmaceutical Regulatory Affairs Revenue by Type (2016-2026)

6.2 North America Pharmaceutical Regulatory Affairs Revenue by Application (2016-2026)

6.3 North America Pharmaceutical Regulatory Affairs Market Size by Country

6.3.1 North America Pharmaceutical Regulatory Affairs Revenue by Country (2016-2026)

6.3.2 United States Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

6.3.3 Canada Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

6.3.4 Mexico Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Pharmaceutical Regulatory Affairs Revenue by Type (2016-2026)

7.2 Europe Pharmaceutical Regulatory Affairs Revenue by Application (2016-2026)

7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Country

7.3.1 Europe Pharmaceutical Regulatory Affairs Revenue by Country (2016-2026)

7.3.2 Germany Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

7.3.3 France Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

7.3.5 Russia Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

7.3.6 Italy Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Type (2016-2026)

8.2 Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Application (2016-2026)

8.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region

8.3.1 Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Region (2016-2026)

8.3.2 China Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

8.3.3 Japan Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

8.3.4 South Korea Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

8.3.5 India Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

8.3.7 Australia Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Pharmaceutical Regulatory Affairs Revenue by Type (2016-2026)

9.2 South America Pharmaceutical Regulatory Affairs Revenue by Application (2016-2026)

9.3 South America Pharmaceutical Regulatory Affairs Market Size by Country

9.3.1 South America Pharmaceutical Regulatory Affairs Revenue by Country (2016-2026)

9.3.2 Brazil Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

9.3.3 Argentina Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Type (2016-2026)

10.2 Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Application (2016-2026)

10.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country

10.3.1 Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Country (2016-2026)

10.3.2 Turkey Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

10.3.4 UAE Pharmaceutical Regulatory Affairs Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharmaceutical Regulatory Affairs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Pharmaceutical Regulatory Affairs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Pharmaceutical Regulatory Affairs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Pharmaceutical Regulatory Affairs Revenue (USD Million) by Region (2016-2021)

Table 5. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Region (2021-2026)

Table 6. QuintilesIMS Corporate Information, Head Office, and Major Competitors

Table 7. QuintilesIMS Major Business

Table 8. QuintilesIMS Pharmaceutical Regulatory Affairs Product and Solutions

Table 9. QuintilesIMS Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. LabCor Corporate Information, Head Office, and Major Competitors

Table 11. LabCor Major Business

Table 12. LabCor Pharmaceutical Regulatory Affairs Product and Solutions

Table 13. LabCor Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. PAREXEL Corporate Information, Head Office, and Major Competitors

Table 15. PAREXEL Major Business

Table 16. PAREXEL Pharmaceutical Regulatory Affairs Product and Solutions

Table 17. PAREXEL Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Pharmaceutical Product Development Corporate Information, Head Office, and Major Competitors

Table 19. Pharmaceutical Product Development Major Business

Table 20. Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product and Solutions

Table 21. Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. INC RESEARCH HOLDINGS Corporate Information, Head Office, and Major Competitors

Table 23. INC RESEARCH HOLDINGS Major Business

Table 24. INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product and Solutions

Table 25. INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. PRA Health Sciences Corporate Information, Head Office, and Major Competitors

Table 27. PRA Health Sciences Major Business

Table 28. PRA Health Sciences Pharmaceutical Regulatory Affairs Product and Solutions

Table 29. PRA Health Sciences Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. ICON Corporate Information, Head Office, and Major Competitors

Table 31. ICON Major Business

Table 32. ICON Pharmaceutical Regulatory Affairs Product and Solutions

Table 33. ICON Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Charles River Corporate Information, Head Office, and Major Competitors

Table 35. Charles River Major Business

Table 36. Charles River Pharmaceutical Regulatory Affairs Product and Solutions

Table 37. Charles River Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Advent International Corporate Information, Head Office, and Major Competitors

Table 39. Advent International Major Business

Table 40. Advent International Pharmaceutical Regulatory Affairs Product and Solutions

Table 41. Advent International Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. WuXi AppTec, Inc. Corporate Information, Head Office, and Major Competitors

Table 43. WuXi AppTec, Inc. Major Business

Table 44. WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product and Solutions

Table 45. WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Pharmaron Beijing Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 47. Pharmaron Beijing Co., Ltd. Major Business

Table 48. Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product and Solutions

Table 49. Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Hangzhou Tigermed Consulting Co.,Ltd. Corporate Information, Head Office, and Major Competitors

Table 51. Hangzhou Tigermed Consulting Co.,Ltd. Major Business

Table 52. Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product and Solutions

Table 53. Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Asymchem Laboratories (Tianjin) Co.,Ltd. Corporate Information, Head Office, and Major Competitors

Table 55. Asymchem Laboratories (Tianjin) Co.,Ltd. Major Business

Table 56. Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product and Solutions

Table 57. Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Accell Clinical Research, LLC. Corporate Information, Head Office, and Major Competitors

Table 59. Accell Clinical Research, LLC. Major Business

Table 60. Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product and Solutions

Table 61. Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. GenPact Ltd. Corporate Information, Head Office, and Major Competitors

Table 63. GenPact Ltd. Major Business

Table 64. GenPact Ltd. Pharmaceutical Regulatory Affairs Product and Solutions

Table 65. GenPact Ltd. Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Criterium, Inc. Corporate Information, Head Office, and Major Competitors

Table 67. Criterium, Inc. Major Business

Table 68. Criterium, Inc. Pharmaceutical Regulatory Affairs Product and Solutions

Table 69. Criterium, Inc. Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Promedica International Corporate Information, Head Office, and Major Competitors

Table 71. Promedica International Major Business

Table 72. Promedica International Pharmaceutical Regulatory Affairs Product and Solutions

Table 73. Promedica International Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Medpace Corporate Information, Head Office, and Major Competitors

Table 75. Medpace Major Business

Table 76. Medpace Pharmaceutical Regulatory Affairs Product and Solutions

Table 77. Medpace Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Covance Corporate Information, Head Office, and Major Competitors

Table 79. Covance Major Business

Table 80. Covance Pharmaceutical Regulatory Affairs Product and Solutions

Table 81. Covance Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Freyr Corporate Information, Head Office, and Major Competitors

Table 83. Freyr Major Business

Table 84. Freyr Pharmaceutical Regulatory Affairs Product and Solutions

Table 85. Freyr Pharmaceutical Regulatory Affairs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global Pharmaceutical Regulatory Affairs Revenue (USD Million) by Players (2019-2021)

Table 87. Global Pharmaceutical Regulatory Affairs Revenue Share by Players (2019-2021)

Table 88. Breakdown of Pharmaceutical Regulatory Affairs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Pharmaceutical Regulatory Affairs Players Head Office, Products and Services Provided

Table 90. Pharmaceutical Regulatory Affairs Mergers & Acquisitions in the Past Five Years

Table 91. Pharmaceutical Regulatory Affairs New Entrants and Expansion Plans

Table 92. Global Pharmaceutical Regulatory Affairs Revenue (USD Million) by Type (2016-2021)

Table 93. Global Pharmaceutical Regulatory Affairs Revenue Share by Type (2016-2021)

Table 94. Global Pharmaceutical Regulatory Affairs Revenue Forecast by Type (2021-2026)

Table 95. Global Pharmaceutical Regulatory Affairs Revenue by Application (2016-2021)

Table 96. Global Pharmaceutical Regulatory Affairs Revenue Forecast by Application (2021-2026)

Table 97. North America Pharmaceutical Regulatory Affairs Revenue by Type (2016-2021) & (USD Million)

Table 98. North America Pharmaceutical Regulatory Affairs Revenue by Type (2021-2026) & (USD Million)

Table 99. North America Pharmaceutical Regulatory Affairs Revenue by Application (2016-2021) & (USD Million)

Table 100. North America Pharmaceutical Regulatory Affairs Revenue by Application (2021-2026) & (USD Million)

Table 101. North America Pharmaceutical Regulatory Affairs Revenue by Country (2016-2021) & (USD Million)

Table 102. North America Pharmaceutical Regulatory Affairs Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe Pharmaceutical Regulatory Affairs Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe Pharmaceutical Regulatory Affairs Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe Pharmaceutical Regulatory Affairs Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe Pharmaceutical Regulatory Affairs Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe Pharmaceutical Regulatory Affairs Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe Pharmaceutical Regulatory Affairs Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific Pharmaceutical Regulatory Affairs Revenue by Region (2021-2026) & (USD Million)

Table 115. South America Pharmaceutical Regulatory Affairs Revenue by Type (2016-2021) & (USD Million)

Table 116. South America Pharmaceutical Regulatory Affairs Revenue by Type (2021-2026) & (USD Million)

Table 117. South America Pharmaceutical Regulatory Affairs Revenue by Application (2016-2021) & (USD Million)

Table 118. South America Pharmaceutical Regulatory Affairs Revenue by Application (2021-2026) & (USD Million)

Table 119. South America Pharmaceutical Regulatory Affairs Revenue by Country (2016-2021) & (USD Million)

Table 120. South America Pharmaceutical Regulatory Affairs Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa Pharmaceutical Regulatory Affairs Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Pharmaceutical Regulatory Affairs Picture

Figure 2. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type in 2020

Figure 3. Regulatory Consulting

Figure 4. Legal Representation

Figure 5. Regulatory Writing & Publishing

Figure 6. Product Registration & Clinical Trial Application

Figure 7. Other Services

Figure 8. Pharmaceutical Regulatory Affairs Revenue Market Share by Application in 2020

Figure 9. In-house Picture

Figure 10. Outsourcing Picture

Figure 11. Global Pharmaceutical Regulatory Affairs Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Pharmaceutical Regulatory Affairs Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Region (2016-2026)

Figure 14. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Region in 2020

Figure 15. North America Pharmaceutical Regulatory Affairs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Pharmaceutical Regulatory Affairs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Pharmaceutical Regulatory Affairs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Pharmaceutical Regulatory Affairs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Pharmaceutical Regulatory Affairs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Pharmaceutical Regulatory Affairs Market Drivers

Figure 21. Pharmaceutical Regulatory Affairs Market Restraints

Figure 22. Pharmaceutical Regulatory Affairs Market Trends

Figure 23. QuintilesIMS Recent Developments and Future Plans

Figure 24. LabCor Recent Developments and Future Plans

Figure 25. PAREXEL Recent Developments and Future Plans

Figure 26. Pharmaceutical Product Development Recent Developments and Future Plans

Figure 27. INC RESEARCH HOLDINGS Recent Developments and Future Plans

Figure 28. PRA Health Sciences Recent Developments and Future Plans

Figure 29. ICON Recent Developments and Future Plans

Figure 30. Charles River Recent Developments and Future Plans

Figure 31. Advent International Recent Developments and Future Plans

Figure 32. WuXi AppTec, Inc. Recent Developments and Future Plans

Figure 33. Pharmaron Beijing Co., Ltd. Recent Developments and Future Plans

Figure 34. Hangzhou Tigermed Consulting Co.,Ltd. Recent Developments and Future Plans

Figure 35. Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Developments and Future Plans

Figure 36. Accell Clinical Research, LLC. Recent Developments and Future Plans

Figure 37. GenPact Ltd. Recent Developments and Future Plans

Figure 38. Criterium, Inc. Recent Developments and Future Plans

Figure 39. Promedica International Recent Developments and Future Plans

Figure 40. Medpace Recent Developments and Future Plans

Figure 41. Covance Recent Developments and Future Plans

Figure 42. Freyr Recent Developments and Future Plans

Figure 43. Global Pharmaceutical Regulatory Affairs Revenue Share by Players in 2020

Figure 44. Pharmaceutical Regulatory Affairs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 45. Global Top 3 Players Pharmaceutical Regulatory Affairs Revenue Market Share in 2020

Figure 46. Global Top 10 Players Pharmaceutical Regulatory Affairs Revenue Market Share in 2020

Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 48. Global Pharmaceutical Regulatory Affairs Revenue Share by Type in 2020

Figure 49. Global Pharmaceutical Regulatory Affairs Market Share Forecast by Type (2021-2026)

Figure 50. Global Pharmaceutical Regulatory Affairs Revenue Share by Application in 2020

Figure 51. Global Pharmaceutical Regulatory Affairs Market Share Forecast by Application (2021-2026)

Figure 52. North America Pharmaceutical Regulatory Affairs Sales Market Share by Type (2016-2026)

Figure 53. North America Pharmaceutical Regulatory Affairs Sales Market Share by Application (2016-2026)

Figure 54. North America Pharmaceutical Regulatory Affairs Revenue Market Share by Country (2016-2026)

Figure 55. United States Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Canada Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Mexico Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Europe Pharmaceutical Regulatory Affairs Sales Market Share by Type (2016-2026)

Figure 59. Europe Pharmaceutical Regulatory Affairs Sales Market Share by Application (2016-2026)

Figure 60. Europe Pharmaceutical Regulatory Affairs Revenue Market Share by Country (2016-2026)

Figure 61. Germany Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. France Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. United Kingdom Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Russia Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Italy Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Asia-Pacific Pharmaceutical Regulatory Affairs Sales Market Share by Type (2016-2026)

Figure 67. Asia-Pacific Pharmaceutical Regulatory Affairs Sales Market Share by Application (2016-2026)

Figure 68. Asia-Pacific Pharmaceutical Regulatory Affairs Revenue Market Share by Region (2016-2026)

Figure 69. China Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Japan Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South Korea Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. India Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Southeast Asia Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Australia Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South America Pharmaceutical Regulatory Affairs Sales Market Share by Type (2016-2026)

Figure 76. South America Pharmaceutical Regulatory Affairs Sales Market Share by Application (2016-2026)

Figure 77. South America Pharmaceutical Regulatory Affairs Revenue Market Share by Country (2016-2026)

Figure 78. Brazil Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Argentina Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Middle East and Africa Pharmaceutical Regulatory Affairs Sales Market Share by Type (2016-2026)

Figure 81. Middle East and Africa Pharmaceutical Regulatory Affairs Sales Market Share by Application (2016-2026)

Figure 82. Middle East and Africa Pharmaceutical Regulatory Affairs Revenue Market Share by Country (2016-2026)

Figure 83. Turkey Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Saudi Arabia Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. UAE Pharmaceutical Regulatory Affairs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Methodology

Figure 87. Research Process and Data Source